Shuk, Elyse
Shoushtari, Alexander N.
Luke, Jason
Postow, Michael A.
Callahan, Maggie
Harding, James J.
Roth, Katherine G.
Flavin, Marisa
Granobles, Adrian
Christian, Jana
Gold, Geoffrey
Schoenhammer, Maria
Gordon, Mallorie
Cimaglia, Nicholas
Dyson, Robert
Goodman-Davis, Noah
Colgan, Marta N.
Jefferson, Itisha S.
Munhoz, Rodrigo
D’Angelo, Sandra
Wolchok, Jedd
Chapman, Paul
Chi, Ping
Carvajal, Richard D.
Hay, Jennifer L.
Funding for this research was provided by:
National Institutes of Health (P30 CA08748-48)
Bristol-Myers Squibb (RFP-US-11-CA 184-010)
Memorial Sloan Kettering Cancer Center
Article History
Received: 5 May 2016
Accepted: 6 February 2017
First Online: 1 March 2017
Compliance with ethical standards
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
: This work was supported by Bristol-Myers Squibb [RFP-US-11-CA184-010] initially awarded to Dr. Jason Luke and subsequently held by Drs. Richard D. Carvajal and Jennifer L. Hay and also by the Melanoma Disease Management team at Memorial Sloan Kettering Cancer Center. This project was additionally supported by a National Institutes of Health Support Grant [P30 CA08748-48], which provides partial support for the Behavioral Research Methods Core Facility in the Department of Psychiatry & Behavioral Sciences at Memorial Sloan Kettering Cancer Center, which was used in conducting this investigation. The authors declare no financial relationship with the organization that sponsored this research. The authors have full control of all primary data and allow review of our data if requested.
: None.